Previously, Evans-Molina et al. (34) demonstrated that treatment of mouse models of diabetes and obesity with the PPARγ agonist pioglitazone improved glycemia with enhanced expression of Pdx1 and SetD7 proteins. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.